RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재

      지역 약사의 자발적 부작용 보고에 대한 인식 및 태도와 영향요인 조사: 설문조사 결과를 중심으로 = Investigation on Perceptions, Attitudes, and Contributing Factors to Spontaneous Adverse Drug Reaction Reporting among Community Pharmacists: Results from a Web-based Survey

      한글로보기

      https://www.riss.kr/link?id=A106260022

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Objective: To examine the perceptions and attitudes toward spontaneous adverse drug reaction (ADR) reporting system among community pharmacists and identify factors that influence reporting, by implementing a survey. Methods: A structured questionnair...

      Objective: To examine the perceptions and attitudes toward spontaneous adverse drug reaction (ADR) reporting system among community pharmacists and identify factors that influence reporting, by implementing a survey. Methods: A structured questionnaire was developed and distributed online. Request for the survey was posted on the website of pharmacy’s billing program, and the survey was conducted for 8 days. We collected the participants’ response on their work environment, experience of ADR reporting, and their perception and attitude on the reporting system. Multivariate logistic regression was used to evaluate factors influencing ADR reporting. Results: A total of 382 pharmacists participated in the survey. Significant contributing factors for reporting level were age (odds ratio [OR], 0.90; 95% confidence interval [CI], 0.84-0.96), knowledge of reporting method (OR, 53.56; 95% CI, 9.10-315.41), installation of reporting program (OR, 31.92; 95% CI, 4.16-244.75), and encouragement from the Korean pharmaceutical association (OR, 4.13; 95% CI, 1.11-15.35). Regarding the attitude toward spontaneous ADR reporting system, ‘lack of time for reporting’ (OR, 0.29; 95% CI, 0.15-0.53) and ‘complexity of reporting procedure’ (OR, 0.51; 95% CI, 0.31-0.84), were associated with a low likelihood of reporting. Conclusion: Our results indicated that the knowledge of ADR reporting method, installation of the reporting program, and encouragement from the Korean Pharmaceutical Association contribute to active reporting.
      It is necessary to simplify the reporting method, make the ADR reporting program user-friendly, and provide educational interventions to increase participation in spontaneous reporting by the community pharmacists.

      더보기

      참고문헌 (Reference)

      1 Hazell L, "Under-reporting of adverse drug reactions" 29 (29): 385-396, 2006

      2 Toklu HZ, "The knowledge and attitude of the Turkish community pharmacists toward pharmacovigilance in the Kadikoy district of Istanbul" 30 (30): 556-562, 2008

      3 Korean Pharmaceutical Association, "Strategies for improvement of Adverse Drug Reaction reporting and Drug Utilization Review monitoring system in Korean community pharmacies" Ministry of Food and Drug Safety 2017

      4 Lee A, "Reporting of adverse drug reactions by hospital pharmacists: pilot scheme" 315 (315): 519-, 1997

      5 Yu YM, "Predictive factors of spontaneous reporting of adverse drug reactions among community pharmacists" 11 (11): e0155517-, 2016

      6 World Health Organization, "Pharmacovigilance: ensuring the safe use of medicines. WHO Policy Perspectives on Medicines"

      7 Suyagh M, "Pharmacist’s knowledge, practice and attitudes toward pharmacovigilance and adverse drug reactions reporting process" 23 (23): 147-153, 2015

      8 Granas AG, "Pharmacists’ attitudes towards the reporting of suspected adverse drug reactions in Norway" 16 (16): 429-434, 2007

      9 Vessal G, "Knowledge, attitudes, and perceptions of pharmacists to adverse drug reaction reporting in Iran" 31 (31): 183-187, 2009

      10 Kongkaew C, "Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies" 42 (42): 1017-1025, 2008

      1 Hazell L, "Under-reporting of adverse drug reactions" 29 (29): 385-396, 2006

      2 Toklu HZ, "The knowledge and attitude of the Turkish community pharmacists toward pharmacovigilance in the Kadikoy district of Istanbul" 30 (30): 556-562, 2008

      3 Korean Pharmaceutical Association, "Strategies for improvement of Adverse Drug Reaction reporting and Drug Utilization Review monitoring system in Korean community pharmacies" Ministry of Food and Drug Safety 2017

      4 Lee A, "Reporting of adverse drug reactions by hospital pharmacists: pilot scheme" 315 (315): 519-, 1997

      5 Yu YM, "Predictive factors of spontaneous reporting of adverse drug reactions among community pharmacists" 11 (11): e0155517-, 2016

      6 World Health Organization, "Pharmacovigilance: ensuring the safe use of medicines. WHO Policy Perspectives on Medicines"

      7 Suyagh M, "Pharmacist’s knowledge, practice and attitudes toward pharmacovigilance and adverse drug reactions reporting process" 23 (23): 147-153, 2015

      8 Granas AG, "Pharmacists’ attitudes towards the reporting of suspected adverse drug reactions in Norway" 16 (16): 429-434, 2007

      9 Vessal G, "Knowledge, attitudes, and perceptions of pharmacists to adverse drug reaction reporting in Iran" 31 (31): 183-187, 2009

      10 Kongkaew C, "Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies" 42 (42): 1017-1025, 2008

      11 Irujo M, "Factors that influence under-reporting of suspected adverse drug reactions among community pharmacists in a Spanish region" 30 (30): 1073-1082, 2007

      12 Ortega A, "Efficacy of an adverse drug reaction electronic reporting system integrated into a hospital information system" 42 (42): 1491-1496, 2008

      13 Lopez-Gonzalez E, "Effect of an educational intervention to improve adverse drug reaction reporting in physicians: a cluster randomized controlled trial" 38 (38): 189-196, 2015

      14 Lopez-Gonzalez E, "Determinants of under-reporting of adverse drug reactions: a systematic review" 32 (32): 19-31, 2009

      15 Mahmoud MA, "Community pharmacists’ knowledge, behaviors and experiences about adverse drug reaction reporting in Saudi Arabia" 22 (22): 411-418, 2014

      16 Green CF, "Attitudes and knowledge of hospital pharmacists to adverse drug reaction reporting" 51 (51): 81-86, 2001

      17 Kim J, "Analysis of characteristics about spontaneous reporting-reported in 2008" 3 : 23-31, 2010

      18 Shamim S, "Adverse drug reactions (ADRS) reporting: awareness and reasons of under-reporting among health care professionals, a challenge for pharmacists" 5 (5): 1778-, 2016

      19 Classen DC, "Adverse drug events in hospitalized patients: excess length of stay, extra costs, and attributable mortality" 277 (277): 301-306, 1997

      20 Choi N, "A survey on attitudes and awareness of physicians and pharmacists regarding spontaneous reporting system and experience for adverse drug events in Goyangsi" 1 : 44-52, 2008

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2027 평가예정 재인증평가 신청대상 (재인증)
      2021-01-01 평가 등재학술지 유지 (재인증) KCI등재
      2018-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2015-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2011-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2009-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2006-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2005-05-10 학술지등록 한글명 : 한국임상약학회지
      외국어명 : Korean Journal of Clinical Pharmacy
      KCI등재후보
      2005-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2003-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.18 0.18 0.17
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.17 0.15 0.432 0.02
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼